Schizophrenia: all 3,539 studies
Page 23 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Linagliptin and Mesenchymal Stem Cells: A Pilot StudyCompletedNCT02442817Phase 4
- Treating Social Cognition With Theta Burst Stimulation; a Pilot SudyStatus unknownNCT02440867Not applicable
- Retinoic Acid Homeostasis in Neuropsychiatric DiseasesStatus unknownNCT02439099
- The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong KongCompletedNCT02435784Not applicable
- 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset SchizophreniaCompletedNCT02435654Phase 4
- Antipsychotic Induced Structural and Functional Brain ChangesTerminatedNCT02435095Phase 4
- A Pharmacokinetic Study of Paliperidone ERStatus unknownNCT02433717Phase 4
- The Music Study in Refractory PsychosisStatus unknownNCT02431949
- Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory DiscriminationStatus unknownNCT02426983Phase 1/2
- Neuroendocrine and Metabolite Substrates in SchizophreniaStatus unknownNCT02423096
- Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessCompletedNCT02421965Not applicable
- Trial of Treatment for Internalized Stigma in SchizophreniaCompletedNCT02421237Not applicable
- OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) GrantCompletedNCT02415764Phase 1
- Multimodal Physical Therapy Program in SchizophreniaCompletedNCT02413164Not applicable
- Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With SchizophreniaCompletedNCT02411695Phase 1
- Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaCompletedNCT02411526Phase 1
- Clinical Registry of Patients Under Treatment With Atypical AntipsychoticsCompletedNCT02409823
- Integrated Coping and Awareness TrainingCompletedNCT02400502Not applicable
- A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With PsychosisCompletedNCT02398292Not applicable
- L-arginine add-on Therapy in Patients With SchizophreniaCompletedNCT02398279Not applicable
- Problem-solving-based Bibliotherapy Program for Family CaregiversCompletedNCT02391649Not applicable
- How Reducing Anxiety in SchizophreniaCompletedNCT02390271Phase 4
- Sustained Attention Abilities in SchizophreniaStatus unknownNCT02388607
- Efficiency of Art-therapy in Psychotic DisordersTerminatedNCT02383095Not applicable
- Characterization of the Motivational Deficit in Schizophrenia and DepressionStatus unknownNCT02378818Not applicable
- Deep Brain Stimulation in Treatment Resistant SchizophreniaCompletedNCT02377505Not applicable
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health ProblemsStatus unknownNCT02366117Not applicable
- Improving Care and Reducing Cost StudyCompletedNCT02364544Not applicable
- Cognitive Remediation Therapy Within a Secure Forensic SettingCompletedNCT02360813Not applicable
- Participatory Video as a Recovery-Oriented Intervention in Early PsychosisCompletedNCT02360566Not applicable
- Adjunctive Vortioxetine in SchizophreniaActive, not recruitingNCT02357797Phase 4
- Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaCompletedNCT02354001Phase 4
- A Shared Decision-making Training for Inpatients With SchizophreniaCompletedNCT02349880Not applicable
- Mindfulness Group-based Intervention for Early Psychosis: A Pilot StudyCompletedNCT02342210Not applicable
- Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF LevelsCompletedNCT02341131Not applicable
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia IICompletedNCT02339844Phase 4
- Perceptual Deficits in SchizophreniaStatus unknownNCT02337439Not applicable
- Researching the Effectiveness of Acceptance-Based Coping During HospitalizationCompletedNCT02336581Not applicable
- Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMICompletedNCT02334280Not applicable
- Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessCompletedNCT02334228Not applicable
- Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal SubjectsCompletedNCT02331433Phase 1
- Psychiatric Disorders and Electrophysiological MarkersStatus unknownNCT02329119Not applicable
- Exercise and Cognitive TrainingCompletedNCT02326389Not applicable
- The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis DisorderStatus unknownNCT02322918
- Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up StudyCompletedNCT02321943
- An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaCompletedNCT02320032Phase 1
- Task Sharing for the Care of Severe Mental Disorders in a Low-income CountryCompletedNCT02308956Phase 3
- Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill ParentsCompletedNCT02308462Not applicable
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisCompletedNCT02305823Phase 4
- Dyad Oxytocin Study (DOS)CompletedNCT02302209Phase 1
- Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia PatientsCompletedNCT02298985Phase 4
- Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable SchizophreniaCompletedNCT02288845Phase 2
- Study of the Effect of Dosing on Clozapine LevelsWithdrawnNCT02286206Phase 4
- A Problem-solving Based Bibliotherapy Program for Family Caregivers in SchizophreniaCompletedNCT02283437Not applicable
- Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With SchizophreniaStatus unknownNCT02282085Phase 4
- The Influence of Vitamin D on Atypical Antipsychotic-induced Weight GainCompletedNCT02281162
- Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeCompletedNCT02267070Not applicable
- Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in AdultsTerminatedNCT02261519Phase 2/3
- Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167CompletedNCT02260830Phase 1
- Assertive Community Treatment With CBT and SST for SchizophreniaCompletedNCT02254733Not applicable
- Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in SchizophreniaCompletedNCT02248987
- Treatment of Social Cognition in Schizophrenia TrialCompletedNCT02246426Not applicable
- Schizophrenia for "Life" - a Registry and Interview Study Among Elderly With Lifelong SchizophreniaCompletedNCT02246283
- Compensatory Cognitive Training in Clinical High Risk Latino YouthStatus unknownNCT02245607Not applicable
- Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia PatientsWithdrawnNCT02240446Not applicable
- Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of SchizophreniaStatus unknownNCT02240173Phase 1/2
- Effect of Memantine on ERP in Early Schizophrenia and Healthy SubjectsStatus unknownNCT02233556Not applicable
- Pharmacokinetic Study of MIN-101 in Healthy SubjectsCompletedNCT02232529Phase 1
- tDCS & Auditory Hallucinations in SchizophreniaTerminatedNCT02227563Not applicable
- Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body SensorsCompletedNCT02224430
- 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsCompletedNCT02220504Not applicable
- Psychosis and Affective Research Domains and Intermediate PhenotypesCompletedNCT02218853
- Electronic Cigarettes in Smokers With Mental IllnessCompletedNCT02212041Not applicable
- Omega-3 Fatty Acids Efficacy in First-episode of SchizophreniaStatus unknownNCT02210962Phase 4
- Effects of Physical Activity in PsychosisStatus unknownNCT02205684Not applicable
- Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaStatus unknownNCT02205437
- A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable SchizophreniaCompletedNCT02205099Phase 1/2
- Treatment of Negative Symptoms and SchizophreniaCompletedNCT02204787Phase 1/2
- Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With SchizophreniaCompletedNCT02202226Phase 1
- Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With SchizophreniaCompletedNCT02202213Phase 1
- Effects of a Cognitive Rehabilitation Program: a Neurocognitive StudyCompletedNCT02201888Not applicable
- Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIPStatus unknownNCT02200588
- Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case SeriesCompletedNCT02199704Not applicable
- Targeted Vitamin D Treatment of Schizophrenia-Associated HyperprolinemiaWithdrawnNCT02197286Phase 2
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for SchizophreniaCompletedNCT02192723Not applicable
- Computerized Cognitive-Behavioral Therapy for Auditory HallucinationsCompletedNCT02192593Not applicable
- Self-Management Training and Automated Telehealth to Improve SMI Health OutcomesCompletedNCT02188732Not applicable
- Decreased EEG Complexity in SchizophreniaCompletedNCT02187835
- The Effectiveness of the Meta-cognitive Training Among Patients With Chronic SchizophreniaCompletedNCT02187692Not applicable
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02186769Phase 1
- A System for Preference Assessment in Mental HealthCompletedNCT02183844Not applicable
- The Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot StudyCompletedNCT02176044Phase 1
- Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in SchizophreniaCompletedNCT02175251Not applicable
- Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'OrCompletedNCT02167724Not applicable
- Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental IllnessCompletedNCT02167620Phase 4
- Factors Influencing Social Functioning of People With SchizophreniaCompletedNCT02166918
- RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)CompletedNCT02160249Not applicable
- Electroconvulsive Therapy in Clozapine-resistant SchizophreniaStatus unknownNCT02159001Not applicable